Skip to main content
Unexpected redundancy of Gpr56 and Gpr97 during hematopoietic cell development and differentiation.
A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant.
Diagnostic assay to assist clinical decisions for unclassified severe combined immune deficiency.
Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease.
American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.
TA-TMA: state of the art for diagnosis and treatment.
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.
Paroxysmal cold hemoglobinuria successfully treated with complement inhibition.
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.
Related and unrelated donor transplantation for ß-thalassemia major: results of an international survey.